Background {#Sec1}
==========

Mechanical ventilation (MV) with positive end-expiratory pressure (PEEP) is often required in patients with severe traumatic brain injury (sTBI) due to neurologic, airway, and pulmonary dysfunctions \[[@CR1], [@CR2]\]. Application of PEEP during MV is essential to improving oxygenation and protecting from mechanical lung injury, by increasing functional residual capacity, preventing atelectasis, reducing oxygen requirement, and raising static strain component \[[@CR3]--[@CR5]\]. .

However, the influence of PEEP on intracranial pressure (ICP) has been an obstacle to the optimal use of PEEP for a long time \[[@CR6]\]. The effect of PEEP on ICP was first mentioned in the later 1970s \[[@CR7], [@CR8]\]. In the last three decades, several studies have explored the relationship between PEEP and ICP, but without consistent results \[[@CR1]\]. Shapiro et al. demonstrated that PEEP application in the 4--8 cm H~2~O range increases ICP (\> 10 mmHg) \[[@CR7]\]. Flexman and colleagues also found that alveolar recruitment maneuvers increase subdural pressure and reduce cerebral perfusion pressure (CPP) in neurosurgery \[[@CR9]\]. A recent study by Boone et al. found that every centimeter H~2~O increase of PEEP contributes to a 0.31 mmHg increase in ICP \[[@CR10]\], and concluded that PEEP might exert adverse effects on cerebral hemodynamics by impeding cerebral venous return and elevating ICP in patients with sTBI. However, other studies found no effects of moderate to high levels of PEEP (8--25 cmH~2~O) on ICP, CPP, and cerebral blood flow (CBF) in sTBI patients with normal ICP or intracranial hypertension, and PEEP instead exerted favorable effects by improving brain tissue oxygen pressure and saturation \[[@CR11]--[@CR14]\]. Such discrepancy might be related to several factors: (1) individual heterogeneity, mainly involving the severity of and baseline ICP \[[@CR15]\]; (2) not fully understood dose-effect relationship between PEEP and ICP; and (3) it is unclear whether PEEP directly affects ICP or indirectly through an intermediate.

To date, no indicators for predicting the influence of PEEP on ICP have been reported. Theoretically, increasing intrathoracic pressure by PEEP may hinder cerebral venous return and increase ICP during MV in patients with sTBI, and the relationship between CVP and PEEP has been clarified \[[@CR16], [@CR17]\]. Therefore, we hypothesized that: (1) CVP could act as a mediator between PEEP and ICP; (2) the effect of PEEP on ICP depends on baseline ICP and baseline CVP according to the Starling resistor model (Fig. [1](#Fig1){ref-type="fig"}). Herein, we developed a new indicator, P~IC~Gap, which represents the difference between baseline ICP and baseline CVP (at initial PEEP). The main aim of this study was to explore the predictive efficiency of P~IC~Gap in ICP responsiveness to PEEP adjustment. Fig. 1Schematic diagram of the research hypothesis. CVP1 and CVP2 increased from baseline values when PEEP was elevated from initial PEEP; however, ICP1 and ICP2 remained unchanged in the beginning. Thus, GAP1 and GAP2 were narrowed gradually until they disappeared when PEEP reached PEEP1 and PEEP2 (dark grey and light grey shades). PEEP1 and PEEP2 were critical pressure values (GAP1 = 0 and GAP2 = 0) for patient A and patient B, respectively; thereafter, CVP1 at adjusted-PEEP1 would exceed baseline ICP, which would contribute to an elevation of ICP1, and likewise for CVP2 at adjusted-PEEP2. CVP and ICP at initial PEEP were termed baseline ICP and baseline CVP, respectively. ICP1 and CVP1 represented intracranial pressure and central venous pressure at different levels of PEEP for patient A. ICP2 and CVP2 referred to intracranial pressure and central venous pressure for patient B. GAP1 and GAP2 were calculated by ICP1-CVP1 and ICP2-CVP2. Abbreviations: CVP, central venous pressure; PEEP, positive end-expiratory pressure; ICP: intracranial pressure; P~IC~Gap: Gap between baseline ICP and baseline CVP

Methods {#Sec2}
=======

Study design and setting {#Sec3}
------------------------

This prospective study was conducted between May 2016 and May 2019 in the intensive care unit (ICU) of Zhoupu Hospital affiliated to Shanghai University of Medicine & Health Sciences. It has been registered at [ClinicalTrials.gov](http://clinicaltrials.gov) (NCT03296293), and approval of the study protocol was granted by the clinical research ethics committee of Zhoupu Hospital (no. ZPYYLL-2016-12). Written informed consent was obtained from the legal representatives of all patients upon admission because of the coma state of the enrolled study patients.

Study participants {#Sec4}
------------------

All patients with sTBI (Glasgow Coma Scale \[GCS\] ≤8) diagnosed via head CT scan, ICP monitoring transducers or catheter, hypoxemia (pulse oxygen saturation \[SpO~2~\] \< 90%) and MV (Dräger Infinity C500, Dräger, Germany) were initially included. The patients whose hypoxemia could not be corrected even by increasing the fraction of inspired oxygen (FiO~2~) by more than 60% in combination with suction and intensive airway management were eventually enrolled. Exclusion criteria included brain death, age below 18 or over 80 years, pregnancy in women, hemodynamic instability (heart rate \[HR\] \> 120 bpm or CPP \[calculated as MAP-ICP\] \< 60 mmHg), pneumothorax, pulmonary bulla, acute myocardial infarction (elevated cardiac troponin T more than 3 times the normal upper limit accompanied by the ST-T change) and neurosurgical intervention.

Treatment and data measurements {#Sec5}
-------------------------------

The treatment process followed the Guidelines for the Management of sTBI \[[@CR18]\]. All patients were placed in the supine position at 30 degrees head of bed elevation and deeply sedated (0.05 mg/kg loading dose, followed by continuous intravenous infusion of midazolam at 0.05--0.3 mg/kg/h and sufentanil at 0.2 μg/kg/h) to maintain a Richmond Agitation-Sedation Scale (RASS) score of − 5 and, thus, to remove the effects of cough and other neuronal and confounding factors on ICP. The ventilator settings remained consistent for all enrolled patients. The tidal volume was adjusted and maintained at 8 mL/kg of the predicted body weight, and the plateau pressure was maintained below 30 cmH~2~O. Support pressure was maintained at 12--14 cmH~2~O; initial PEEP was set at 3 cmH~2~O, and FiO~2~ was set at 35--50% to maintain a SpO~2~ 90%. ICP was continuously monitored (Codman ICP ExpressTM, Johnson, USA) through an intraparenchimal transducer or a ventricular catheter (Codman ICP Transducer, Johnson, USA) that was associated with a closed external ventricular drain in each measurement when applicable. Both central venous and arterial catheters were inserted to measure intra-arterial mean arterial pressure (MAP) and CVP. CPP was maintained at more than 60--65 mmHg. The static compliance of the respiratory system (Cst) recorded from the ventilator was indexed to the predicted body weight of the patient. During the study, end-tidal carbon dioxide pressure (PetCO~2~) (monitoring by Drager Mainstream CO~2~ device, SN: ASHM-0552, Dräger, Germany) was maintained at 30--35 mmHg by adjusting tidal volume and the respiratory rate, in order to avoid any effect of CO~2~ on ICP \[[@CR19]\].

The stepwise increase of PEEP was set according to a method by Lim et al. \[[@CR20]\] when hypoxemia persisted. Briefly, 100%-FiO~2~ was set, and PEEP was increased stepwise (from 3 cmH~2~O to 10 cmH~2~O, and to 15 cmH~2~O) every 2 min, which was a recruitment maneuver known as "extended sigh". ICP, CVP, Cst, PetCO~2~, and CPP at both levels of PEEP (3 cmH~2~O and 15 cmH~2~O) were measured, respectively. After PEEP at 15 cmH~2~O was maintained for 2 min, baseline ventilator setting was resumed.

Based on our research hypothesis and the specific relationship between CVP and PEEP \[[@CR16], [@CR17]\], P~IC~Gap and other measurements (Cst, CPP, ICP, and PetCO~2~) were compared between the responder and non-responder groups, and prediction of ICP responsiveness to PEEP was tested by assessing the area under the receiver operating characteristic (ROC) curve (AUC).

In this study, treatment was provided in case of: (1) CPP \< 60 mmHg (norepinephrine 0.3--1.0 μg/kg/min); (2) ICP \> 25 mmHg (PEEP was restored to 0); (3) increase in pressure plateau \> 35 cmH~2~O (tidal volume was decreased and the respiratory rate was increased to maintain PetCO~2~ at 30--35 mmHg); (4) SpO~2~ declined progressively (PEEP was restored to 0); and (5) suspicion of pneumothorax (PEEP was restored to 0, and chest radiography was undertaken). An equilibration period (≥ 90s) was entailed to ensure a normalized baseline PetCO~2~ through tidal volume and respiratory rate modulation, as described by Flexman and colleagues \[[@CR9]\].

Study outcomes {#Sec6}
--------------

The main outcome was ICP responsiveness to PEEP adjustment from 3 cmH~2~O to 15 cmH~2~O. Because there is no specified definition for ICP responsiveness, we stipulated that response and non-response referred to increments greater than and less than 20% of baseline ICP, respectively. The patients were then classified into the responder and non-responder groups accordingly.

Statistical analysis {#Sec7}
--------------------

Categorical variables were presented as number and percentage, and analyzed by Fisher's exact test. Continuous covariates, including hemodynamic variables ICP, CVP, CPP, Cst, PetCO~2~ and CPP, were expressed as mean ± standard error. One-way analysis of variance (ANOVA) followed by Bonferroni post hoc test was used for multiple comparisons. The predictive roles of P~IC~Gap other related parameters recorded for ICP responsiveness to PEEP were tested by calculating the AUCs of the ROC curves of ICP over the baseline value at two levels of PEEP (3 and 15 cmH~2~O). *P* \<  0.05 was considered statistically significant. All statistical analyses were performed with SPSS 20.0 for windows (IBM Co. NY, USA).

Results {#Sec8}
=======

Patients baseline characteristics between responder group and non-responder group {#Sec9}
---------------------------------------------------------------------------------

From May 2016 to May 2019, a total of 174 patients were included initially. Sixty-two patients were excluded for hemodynamic instability neurosurgical interventions before admission of ICU, and hypoxemia corrected by suction and increase of FiO~2~, and 112 were entered into the final analysis (supplementary materials, Figure Flowchart). Baseline characteristics of the study population in the responder (*n* = 49) and non-responder (*n* = 63) groups are shown in Table [1](#Tab1){ref-type="table"}. Table 1Patients characteristics at PEEP of 3 cmH~2~O between responder group and non-responder groupResponder group (*n* = 49)Non-Responder group (*n* = 63)*p*Male, n (%)31 (41.89)43 (58.11)0.688Age, years, mean (SD)46.96 (11.88)49.02 (10.49)0.334Causes of brain injury, n (%) Cerebral contusion28 (57.1)38 (60.3)0.735 Parenchymal hematoma14 (28.6)17 (27.0)0.852 Subdural hematoma7 (14.3)8 (12.7)0.807GCS, mean (SD)5.43 (1.61)5.16 (1.35)0.336Hemodynamics variables CVP, mmHg, mean (SD)8.18 (2.66)6.54 (2.59)0.001 MAP, mmHg, mean (SD)78.00 (5.55)79.60 (4.57)0.097 ICP, mmHg, mean (SD)9.82 (2.97)13.10 (2.74)\< 0.001 CPP, mmHg, mean (SD)66.67 (4.58)66.51 (4.03)0.840 HR, bpm, mean (SD)74.97 (13.36)78.88 (14.47)0.104P~IC~Gap, mmHg1.63 (1.33)6.55 (2.46)\< 0.001PetCO~2~, mmHg33.00 (3.13)33.05 (3.06)0.931CrsI, ml/kg/cmH~2~O1.30 (0.06)1.31 (0.06)0.865Abbreviations: *GCS* Glasgow coma score; *CVP* Central venous pressure; *MAP* Mean arterial pressure; *HR* Heart rate; *ICP* Intracranial pressure; *CPP* Cerebral perfusion pressure; *PetCO*~*2*~ End-tidal carbon dioxide pressure; *CstI* The static compliance of respiratory system (Cst) indexed to the predicted body weight of the patients

Compared with the non-responder group, the responder group had lower P~IC~Gap (1.63 ± 1.33 versus 6.56 ± 2.46 mmHg; *p* \<  0.001), lower baseline ICP (9.82 ± 2.97 versus 13.10 ± 2.74 mmHg, *p* \< 0.001), and higher baseline CVP (8.18 ± 2.66 versus 6.54 ± 2.59 mmHg, *p* = 0.001).

Effects of PEEP adjustment on CVP, CVP increment and ICP in the responder and non-responder groups {#Sec10}
--------------------------------------------------------------------------------------------------

Adjustment of PEEP from 3 to 15 cmH~2~O increased CVP levels significantly in both groups (Fig. [2](#Fig2){ref-type="fig"}a). There were no significantly differences in CVP increment (ΔCVP) between the responder and non-responder groups (4.39 ± 1.30 versus 4.25 ± 1.58 mmHg; *p* = 0.174) (Fig. [2](#Fig2){ref-type="fig"}b). A significant ICP increase was observed in the responder group with PEEP tuned up from 3 cmH~2~O to 15 mmHg (9.85 ± 2.99 versus 14.48 ± 3.22 mmHg; *p* \< 0.001), with no change in the non-responder group (13.10 ± 2.74 versus 13.71 ± 2.61 mmHg; *p* = 0.196) (Fig. [2](#Fig2){ref-type="fig"}c). Fig. 2Effects of PEEP adjustment on CVP and ICP in the responder and non-responder groups. Adjustment of PEEP from 3 to 15 cmH~2~O increased CVP significantly in both groups (**a**). There was no significantly difference in CVP increment (ΔCVP) between the responder and non-responder groups (**b**). A significant ICP increase was observed in the responder group with PEEP tuned up from 3 cmH~2~O to 15 mmHg, and no change was found in the non-responder group (**c**). Abbreviations: PEEP, positive end-expiratory pressure; ICP, intracranial pressure; CVP, central venous pressure

No severe side effects in terms of ICP, CVP, CPP, and MAP were observed when PEEP was increased to 15 cmH~2~O (supplementary materials, Table [E1](#MOESM1){ref-type="media"}).

Predictive role of P~IC~Gap, baseline ICP, and baseline CVP on the responsiveness of ICP to PEEP adjustment {#Sec11}
-----------------------------------------------------------------------------------------------------------

As shown in Table [1](#Tab1){ref-type="table"}, P~IC~Gap, baseline ICP, and baseline CVP were significantly different between the responder and non-responder groups, and no significant differences were found in the other variables tested. The predictive abilities of P~IC~Gap, baseline ICP, and baseline CVP were assessed through ROC analysis. As shown in Fig. [3](#Fig3){ref-type="fig"}, P~IC~Gap had the strongest predictive ability for ICP responsiveness to PEEP increase (AUC = 0.957, 95%CI 0.918--0.996; *p* \< 0.001) among the three parameters. At a cut off value of 2.5 mmHg, P~IC~Gap had favorable sensitivity (95.24, 95%CI 86.91--98.70%) and specificity (87.6, 95%CI 75.76--94.27%) in predicting ICP responsiveness to PEEP. However, baseline ICP had an overtly weaker predictive ability compared with P~IC~Gap (AUC = 0.782, 95%CI 0.693--0.781; *p* \< 0.001), and baseline CVP had the weakest ability for predicting ICP responsiveness among the three parameters (AUC = 0.660, 95%CI 0.560--0.760; *p* = 0.004). Fig. 3Predictive values of P~IC~Gap, baseline ICP, and baseline CVP for ICP responsiveness to PEEP. Areas under the ROC curves (AUCs) were assessed for various parameters potentially predicting ICP responsiveness to PEEP adjustment. P~IC~Gap had the strongest ability to predict ICP responsiveness to PEEP increase (AUC = 0.957, 95%CI 0.918--0.996; *p* \< 0.001) among the three parameters. Meanwhile, baseline ICP had overtly weaker predictive ability than P~IC~Gap (AUC = 0.782 for baseline ICP, 95%CI 0.693--0.781; *p* \< 0.001), and baseline CVP had the weakest ability to predict the responsiveness (AUC = 0.660 for CVP, 95%CI 0.560--0.760; *p* = 0.004). Abbreviations: P~IC~Gap, gap between baseline ICP and baseline CVP; ICP, intracranial pressure; AUC, area under receiver operating characteristic curve; ROC, receiver operating characteristic

Discussion {#Sec12}
==========

In the present study, in agreement with our hypothesis that CVP may be an intermediary that delivers pressure from PEEP to ICP, we found that ICP was increased after PEEP only with baseline ICP close to CVP, i.e. P~IC~Gap was narrower in the responder group compared with the non-responder group (1.63 ± 1.33 versus 6.55 ± 2.46 mmHg). This indicates that the same increment of CVP (4.39 ± 1.30 versus 4.25 ± 1.58 mmHg) could obliterate P~IC~Gap in the responder group, but not in non-responders (Fig. [1](#Fig1){ref-type="fig"}). We also evaluated whether P~IC~Gap, baseline ICP, and baseline CVP could predict ICP responsiveness to PEEP in patients with sTBI. The results suggested that P~IC~Gap was the strongest predictive indicator among the three parameters. P~IC~Gap less than 2.5 mmHg could predict ICP responsiveness to PEEP tuned up to 15 cmH~2~O. To the best of our best knowledge, this is the first study demonstrating that PEEP-induced changes of ICP depend on P~IC~Gap rather than PEEP itself.

Although cerebral hemodynamics is not governed entirely by extradural venous pressure since normal ICP (8--13 mmHg) is higher than the venous pressure outside the dura (0--5 mmHg), the changes of extradural venous pressure transfer to the brain circulation might rely on a certain situation \[[@CR21]\]. The degree of subdural venous collapse was related to the difference between ICP and extradural venous pressure, and this passive collapse acts as a variable venous outflow resistance. An alteration of extradural venous pressure causes up- or downregulation of venous outflow resistance through the self-regulation of the degree of passive collapse according to the Starling resistor model \[[@CR22]\].

CVP could act as a surrogate marker of extradural venous pressure, because the pressure falling on the jugular vein is negligible in the supine position. A preliminary experiment also showed that CVP values were the same as those of jugular bulb pressure. According to the Starling resistor model \[[@CR22]\], once the value of CVP after PEEP exceeds baseline ICP, venous outflow resistance would be downregulated to the lower limit. In such a situation, the brain circulation would be impeded, with ICP rising accordingly.

The relationship between PEEP and CVP has been validated by previous studies. Stepwise PEEP elevation induces an increase of CVP \[[@CR17]\]. An increase of 12 cmH~2~O in PEEP caused a more than 4 mmHg rise of CVP in the current study, which was consistent with previous findings \[[@CR17]\]. Thus, it is reasonable to infer that PEEP directly increases CVP, and whether CVP after PEEP could increase ICP depends on the extent of P~IC~Gap narrowing by CVP.

The lower the P~IC~Gap, the easier it is for CVP after PEEP to exceed baseline ICP; then, the Starling resistor would lose effectiveness as a result of the elimination of venous outflow resistance. As indicated in Table [1](#Tab1){ref-type="table"}, patients with responsiveness to PEEP adjustment had relatively lower P~IC~Gap compared with the non-responder group. Thus, based on the hypothesis that CVP is an intermediary which connects PEEP to ICP, we found that P~IC~GAP, a new indicator, could provide a rational explanation regarding the underlying mechanism, which also accounts for the individual heterogeneity proposed by Yang and colleagues \[[@CR15]\].

Brain compliance is unfavorable in patients with sTBI because of cerebral edema associated with injury. In this case, cerebral venous return impeded by increased CVP after PEEP would contribute to increasing ICP after P~IC~Gap is narrowed to zero. A study by Robba and colleagues investigated the effects of pneumoperitoneum and the Trendelenburg position on ICP in non-brain injured patients (lower ICP), and demonstrated that both increase ICP \[[@CR23]\]. There was no significant change in arterial blood pressure and CPP in the study. Although CVP was not monitored, increased ICP might be due to an obstruction of cerebral venous return theoretically \[[@CR24]\].

Several studies used baseline ICP to predict the responsiveness of ICP to PEEP, and found that patients with lower baseline ICP have a positive response to various PEEP levels \[[@CR25], [@CR26]\]. These results were consistent with our findings. Individuals with elevated mean baseline ICP experienced no significant changes of ICP during PEEP alteration. However, these studies have not clarified that a certain ICP value could predict ICP responsiveness to PEEP. Our results also showed that baseline ICP was not a more efficient predictive indicator compared with P~IC~Gap.

It should be mentioned that ICP responsiveness to PEEP may be influenced by compliance of the respiratory system \[[@CR27], [@CR28]\]. Assessment of patients with low-compliance lungs showed that cerebral hemodynamics and ICP are not influenced by the application of PEEP, because less compliance may not transmit the increased pressure to the entire intrathoracic space effectively. In the current study, all the enrolled patients had normal compliance (Table [1](#Tab1){ref-type="table"}). In addition, recent studies have challenged the effects of PEEP on ICP, arguing that PEEP may be more related to eventual changes in hemodynamics or lung compliance than affecting CVP \[[@CR29]--[@CR31]\]. For example, it was proposed that ICP markedly increases after PEEP application, but only in case PEEP induces alveolar hyperinflation with subsequent PaCO~2~ increase \[[@CR29]\].

It is known that sTBI patients tend to progress rapidly early after injury; therefore, they were kept in the ICU for 24 h after injury for close monitoring of ICP in this study. To prevent catheter-related infections, the ICP monitoring probe was implanted for no more than 7 days. In case of hypoxemia, increased PEEP was provided for lung recruitment and increased oxygen saturation. The purpose of a PEEP of 15 cmH~2~O during lung recruitment was to avoid the harmful effects of high PEEP (\> 20 cmH~2~O), such as worsened hemodynamics and significantly increased ICP. Consequently, no serious complication was recorded in this study (Table [E1](#MOESM1){ref-type="media"}). In addition, maintaining PEEP at 15 cmH~2~O for 2 min helped achieve pulmonary bloating \[[@CR20]\] and normalize PetCO~2~ to avoid the impact of CO~2~ retention on ICP \[[@CR9]\]. PEEP in this study did not adversely affect hemodynamics in both patient groups (Table [E1](#MOESM1){ref-type="media"}), and there was no significant difference in prognosis between the two groups (Table [E2](#MOESM2){ref-type="media"}).

The limitations of this study should be mentioned. First, the sample size was relatively small for a clinical study. In addition, the effect of PEEP on CBF was not evaluated. However, we maintained PetCO~2~ at the normal level, and ICP elevation was in a permissible range, indicating likely stable CBF. Furthermore, although P~IC~Gap is a dynamic marker, it did not change dramatically in the early stage of TBI in certain patients after neurosurgery, ensuring the predictive value individually.

Conclusions {#Sec13}
===========

The impact of PEEP on ICP depends on the gap between baseline ICP and CVP. P~IC~Gap, a new indicator, could be a potential predictor of ICP responsiveness to PEEP adjustment in patients with sTBI.

Supplementary information
=========================

 {#Sec14}

**Additional file 1: Table S1.** Hemodynamics and respiratory variables at PEEP of 15 cmH~2~O between two groups. **Additional file 2: Table S2.** Comparison of prognosis between two groups.
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